Sublingual Buprenorphine

High Bioavailability, Fast Absorption of Buprenorphine With New Sublingual Wafer

High Bioavailability, Fast Absorption of Buprenorphine With New Sublingual Wafer

By

Preliminary results suggest that a new sublingual buprenorphine wafer may offer high bioavailability and fast absorption for patients treated for acute and chronic pain.

Neonatal Abstinence Syndrome Effectively Treated With Buprenorphine

Neonatal Abstinence Syndrome Effectively Treated With Buprenorphine

In infants with neonatal abstinence syndrome, sublingual buprenorphine reduced the duration of treatment and decreased the length of hospital stay.

Buprenorphine Beneficial in Neonatal Abstinence Syndrome

Buprenorphine Beneficial in Neonatal Abstinence Syndrome

Sublingual buprenorphine is associated with shorter duration of treatment than oral morphine for infants with neonatal abstinence syndrome.

Sign Up for Free e-Newsletters